Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α

Increased levels of hypoxia and hypoxia-inducible factor 1α (HIF-1α) in human sarcomas correlate with tumor progression and radiation resistance. Prolonged antiangiogenic therapy of tumors not only delays tumor growth but may also increase hypoxia and HIF-1α activity. In our recent clinical trial, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeo-Jung, Lee, Hae-June, Kim, Tae-Min, Eisinger-Mathason, TS Karin, Zhang, Alexia Y, Schmidt, Benjamin, Karl, Daniel L, Nakazawa, Michael S, Park, Peter J, Simon, M Celeste, Yoon, Sam S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2013
Materias:
Cancer Cell Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677782/
https://www.ncbi.nlm.nih.gov/pubmed/22684860
http://dx.doi.org/10.1002/ijc.27666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677782/
https://www.ncbi.nlm.nih.gov/pubmed/22684860
http://dx.doi.org/10.1002/ijc.27666

Ejemplares similares